Transarterial chemoembolization (TACE) is a standard treatment for intermediate-stage
hepatocellular carcinoma (HCC). In this review, we summarize recent updates on the use of …

Portal vein involvement is considered one of the most fearful complications of hepatocellular
carcinoma (HCC). Portal vein tumor thrombosis (PVTT) is associated with aggressive tumor …

The Warburg effect is important for cancer cell proliferation. This phenomenon can be
flexible by interaction between glycolysis and mitochondrial oxidation for energy production …

Recently, treatments for unresectable hepatocellular carcinoma (HCC) have undergone
remarkable development. Various systemic chemotherapy drugs have been approved and …

Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including
South Korea. To provide useful and sensible advice for clinical management of patients with …

Background/Aims: Lenvatinib was recently approved as a first-line oral multikinase inhibitor
for unresectable hepatocellular carcinoma (HCC). In this study, we aimed to compare the …

Methods Consecutive HCC patients who received regorafenib or nivolumab after failure of
sorafenib treatment were included. Primary endpoint was overall survival (OS) and …

The comparative efficacy and safety between lenvatinib and hepatic artery infusion
chemotherapy (HAIC) in patients with unresectable hepatocellular carcinoma (HCC) is still …

Purpose Although sorafenib as a standard of care for advanced hepatocellular carcinoma
(HCC) prolongs overall survival (OS), its efficacy is limited owing to its unsatisfactory …

Simple Summary Trans-arterial radioembolization (TARE) can effectively treat patients with
locally advanced hepatocellular carcinoma (HCC). However, TARE is not widely used in …